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To study the biologic response, three commercial calcium phosphate implant materials(Calcitite", PeriograP, Synthograft"') were implanted in cuspid root "windows" in four beagledogs. No implant material was placed in the fourth cuspid window which served as a control.Following mucoperiosteal flap elevation, windows were chiseled in bone to the root surfacewhich allowed implant particles to contact bone, fibrous connective tissue, cementum anddentin without exposure to the oral environment. Animals were sacrificed after 1,3,5 and6 months.
Histologically, all implant materials were well tolerated. At 1 month, implant particles
were surrounded by fibrous tissue. Fibrous tissues filled the control defect. At 3 months,implant sites exhibited partial bony repair with connective tissue surrounding implantparticles. A ring of osteoid surrounded Synthograft particles. Control defect repair wascomplete. At 5 and 6 months, implant sites exhibited advanced, though incomplete, bonyrepair. New bone encompassed the Synthograft particles. It was concluded: 1 ) Control siteshealed most rapidly. 2) Calcitite and Periograft were well tolerated space occupiers. 3)Synthograft was a nidus for bone deposition.
Alloplastic periodontal grafting materials have been
used to stimulate the regeneration of supporting bone
lost from periodontal disease. Ideally, this restoration
of lost alveolar bone should occur by either direct
replacement or induction. Accordingly, the therapeuticvalue of any synthetic calcium phosphate implant ma-
terial must depend upon some means of inducing newbone formation.
Calcium phosphate implants have not been found to
induce new bone formation in the traditional sense.1
However, they have displayed bone growth "guidance"
properties by causing bone to grow into areas it would
otherwise not occupy.3 This property has been termed
"osteoconductivity." In a series of investigations, the
repair of nonperiodontal surgically created defects in
dogs was found to be more rapid when filled with
resorbable tricalcium phosphate implants in compari-
son to unfilled control defects.2 However, investigatorswho surgically created periodontal defects in dogs found
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a more rapid and complete filling of control sites as
compared to porous nonresorbable hydroxylapatite4 or
porous resorbable tricalcium phosphate implants.5,6 In
contrast to the above, similar rates of healing werefound in a study comparing unfilled surgically createdperiodontal defects with defects containing dense non-resorbable hydroxylapatite implants7
The histologie features associated with calcium phos-phate implantation have included a negligible inflam-
matory or foreign body response.8 New bone depositionhas been found to occur either directly upon the cal-cium phosphate implant surface8,9 or adjacent to an
intervening fibrous tissue capsule surrounding the im-plant.6 Varying rates and degrees of résorption of dif-ferent calcium phosphate implants have also been de-
scribed depending upon their composition and/or den-sity.3
The purposes of this study were to use a periodontalmodel in dogs where communication with the oral
environment was prevented, and to histologically eval-
uate the biologic response to three commercially avail-able calcium phosphate implant materials compared to
unfilled control sites. A biologically "closed" system
essentially eliminated any potentially adverse influence




of the different implant materials under similarly ideal
healing conditions.
MATERIALS AND METHODS
Four 5 to 7-year-old female beagle dogs were used in
this study. Each exhibited generalized moderate Perio-
dontitis with 4 to 5 mm pockets and bone loss 3 to 4
mm apical to the cementoenamel junctions (CEJs) as
determined radiographically. Hygienic phase proce-
dures consisted of a single scaling and root planing
session, and thereafter toothbrushing was done 3 times
weekly throughout the duration of the investigation.
The animals were fed a hard diet of Purina Dog Chow
and water ad libitum.
One month following scaling and root planing, sur-
gery was performed on the facial aspects ofall maxillary
and mandibular cuspid teeth. Pocket depths for the
cuspid teeth did not exceed 3 mm and bleeding was not
elicited upon gentle probing. The animals were anes-
thetized with acepromazine and sodium pentobarbital.
Following local infiltration anesthesia (Xylocaine" with
1/50,000 epinephrine), a vertical releasing incision was
made followed by mucoperiosteal flap elevation to ex-
pose approximately 1 cm of facial supporting alveolar
bone, apicoincisally. A rectangular "window" (5 x
5 mm) was next chiseled through the alveolar bone to
the root surface over the midsection of the cuspid root
(Fig. 1 ). The method of treatment was then randomly
assigned as either Calcitite,* Periograf,f Synthografti
or control. Each of the three implant materials was
placed into a separate "root window" in each dog. The
flap was then reapproximated near its preoperative level
and sutured to completely cover the surgical site with
extreme care being taken not to displace the implant
particles. Firm finger pressure with moist saline gauze
was maintained for 5 minutes for additional implant
particle stabilization. The implant materials, thereby,
simultaneously contacted bone, fibrous connective tis-
sue, cementum and dentin (in areas of inadvertent
cementum removal during window preparation). The
fourth cuspid window in each animal served as a control
with no graft material placed into this surgical defect.
These windows provided the opportunity to evaluate
the biologic response to the calcium phosphate implant
materials in an essentially inflammation-free periodon-
tal environment isolated from the oral environment.
The animals were then maintained on a soft diet with
toothbrushing every other day until the sutures were
removed 1 week postoperatively. Antibiotic therapy
was not given postoperatively. After the 1st week, the
animals were returned to their preoperative diet and
oral hygiene regime. The animals were sacrificed after
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Figure 1. Clinical photograph ofprepared cuspid "window" (arrow)
in beagle dog. Note "window" is surrounded by alveolar bone.
1-, 3-, 5- and 6-month postoperative intervals. Tissue
was formalin-fixed, decalcified in 20% formic acid and
embedded in paraffin. Sections were stained with he-
matoxylin and eosin and evaluated microscopically. A
cross-sectional orientation of the specimens was used
during all histological evaluations.
RESULTS
Clinically, no adverse reactions to the implant ma-
terials were apparent during the six-month postopera-
tive period. Surgical wounds healed without complica-
tion. There was no swelling or redness associated with
the implant sites.
Histologically, all implant materials could be identi-
fied in the surgical defects and were distinguishable
from each other only by their characteristic particle
shapes. Calcitite particles were irregularly shaped with
rounded, smooth margins (Fig. 2A). Periograf particles
were identifiable as being more angular and less regu-
larly shaped (Fig. 5), while Synthograft particles were
spherical in shape (Fig. 6).
One-Month Results. The dense connective tissue
stroma surrounding the Calcitite particles (Fig. 2A) was
representative of the 1-month findings for all grafted
materials. In Figure 2A the bony margin of the sur-
gically created defect was in close proximity to one of
the implant particles, with the periodontal membrane
found to be artifactually separated from the underlying
root surface. The osseous defect margins exhibited
osteoblastic hyperplasia and osteoid formation (Fig.
2B). Osteoclasts were also observed in the remodeling
process.
At 1 month, the unfilled control defects were com-
pletely filled with fibrous connective tissue. Similar to
the experimental sites, osteoblasts and osteoid were
observed at the defect margins.
Three-Month Results. After 3 months, both Calcitite
and Periograf particles continued to be closely sur-
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Figure 2. A. Two-rounded irregularly shaped Calcitile particles (ar-
rows) surrounded at 1 month by a dense connective tissue stroma.
The osseous defect margin is in close proximity to one ofthe implant
particles (right side) with the periodontal membrane artifactually
separatedfrom the underlying root surface (magnification x 100). B.
Higher magnification ofthe osseous defect margin showing Osteoblast
hyperplasia and osteoidformation. Note implant particle above (mag-
nification x 250).
rounded by fibrous connective tissue. Partial bony re-
pair at the defect margins was observed in the form of
osteoblasts with adjacent osteoid formation. There was
also evidence of new cementum in all defects.
After 3 months, the Synthograft experimental sites
presented an additional finding. The Synthograft par-
ticles were surrounded by a ring ofeosinophilic material
suggestive of osteoid (Fig. 3). Cells with dark-staining
nuclei consistent with osteoblasts were observed in close
approximation to the eosinophilic material.
Bony repair was essentially complete after 3 months
in the control sites where no calcium phosphate parti-
cles had been placed (Fig. 4). The presence of increased
numbers of osteoblasts and the marked cellularity of
the periodontal membrane was indicative of the active
repair which occurred within the control defects.
Five- and 6-Month Results. At 5 and 6 months,
advanced, though incomplete, bony repair was evident
at all experimental sites. Both Calcitite and Periograf
(Fig. 5) implant particles continued to be surrounded
by a fibrous connective tissue stroma.
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Figure 3. Synthograft implant site at 3 months showing two spherical
implant particles being surrounded by an eosinophilic material (ar-
rows) suggestive ofosteoid (magnification x 400).
Figure 4. Control defect at 3 months showing repair. Note thinned
cementum following surgical preparation (arrows) (magnification X
100).
Figure 5. Site ofsurgical defect at 6 months showing new islands of
bone (arrows) achieved with angular Periografparticles. Note tooth al




After 5 and 6 months, the Synthograft sites still
presented a unique appearance (Fig. 6) compared to
areas of Periograf and Calcitite implantation. New
bone, as evidenced by osteocytes and osteoid, encom-
passed the spherical Synthograft particles, which in
some areas became contiguous with the regenerated
alveolar bone. Synthograft particles could be seen sur-
rounded by hard tissue (Fig. 7) considered to be new
cementùm due to its continuity with the root surface.
The 5- and 6-month control sites exhibited an ap-
pearance similar to that found after 3 months when
bony repair was considered complete.
DISCUSSION
The rate of surgical repair of control defects as com-
pared to calcium phosphate implanted defects has been
found to vary depending upon the type of implant
material5 7 and location of the defect site.2 5 In a study
of nonresorbable hydroxylapatite implant material
Figure 6. Synthograft implant site at 6 months showing spherical
"nplant particles (arrows). Implant material is surrounded by bone
and is continuous with alveolar bone (left side). Dentin and cementum
°J tooth are noted below (magnification x 100).
figure 7. Synthograft implant site at 6 months showing implant
Particle (arrow) incorporated into repaired cementum ofhxilh below
(magnification x 250).
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placed into surgically created periodontal defects in
dogs, the empty control sites demonstrated complete
healing with new bone after 16 weeks, whereas the
implanted sites still contained large amounts of prolif-
erating fibrovascular tissue.4 Similar results were ob-
tained in the present study with bony repair of the
unfilled control defects being essentially complete after
3 months. In contrast, healing of the calcium phosphate
implant sites was relatively incomplete through the 6-
month duration of the investigation. In this closed,
virtually inflammation-free, dog-periodontal-defect
model, the three commercially available calcium phos-
phate implants evaluated were well-tolerated clinically
and histologically, but did not hasten the healing proc-
ess.
The bone guiding or "osteoconductive" properties of
the calcium phosphate implants have been discussed
by several investigators.2 510 Histologie evidence ofbone
deposition either in direct contact with the calcium
phosphate implant4 810 or within the adjacent connec-
tive tissue5 6 has frequently been suggested to be due, at
least in part, to the presence of the implant material.
However, direct bone apposition against the implant
surface may simply reflect the inert, noninflammatory
and highly biocompatible nature of calcium phosphate
implants1214 rather than any inherent bone inducing
capability of the implant. Other investigators have re-
garded the fibrous connective tissue frequently observed
surrounding the implants to be more of a fibrous scar"
or capsule12" with the implant acting as a biocompa-
tible "filler." In this study, because the nonresorbable
hydroxylapatite implants (Calcitite and Periograf) were
always surrounded by fibrous connective tissue and did
not appear to be directly influencing bone deposition,
they could be also regarded as biocompatible "filler."
Other investigators found that when resorbable tri-
calcium phosphate implants were used to fill intrabony
defects in dogs, after 6 weeks, an eosinophilic "collagen-
like" material was found surrounding islands of what
the authors interpreted as increased collagen forma-
tion.5 While these ceramic-filled defects healed slower
than the unfilled control defects, the investigators felt
the implants had initiated new bone formation. After 3
months, the "resorbable" tricalcium phosphate implant
particles used in this study (Synthograft) were found to
be associated with a ring of eosinophilic material con-
sistent with osteoid. The unique appearance of the
tricalcium phosphate implants was persistent after 6
months with the presence of new bone, as evidenced
by osteocytes and osteoid, encompassing the graft par-
ticles. Whether the observed presence of new bone
directly approximating the tricalcium phosphate parti-
cles represented bone guidance or was simply the result
of normal osseous repair adjacent to a highly biocom-
patible material undergoing résorption cannot be deter-
mined from this study. Also, the potential for the
induction of ankylosis at the implant tooth interface
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could not be determined.3 Further investigation of this
interaction between hard tissues and "resorbable" tri-
calcium phosphate appears warranted.
It may be concluded, within the limits of this study,
that:
1. Control sites healed more rapidly than experimen-
tal sites.
2. The hydroxylapatite implants (Calcitite and Per-
iograf) caused a negligible inflammatory response
and periparticle fibrosis. They may be regarded as
well-tolerated space occupiers.
3. The tricalcium phosphate implant (Synthograft)
caused a negligible inflammatory response and
appeared to serve as a nidus for bone and cemen-
tum deposition.
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Abstracts
A Comparative Study of the Desensitizing Effects of
Dentifrices Containing Sodium Monofluorophosphate and
Formalin
Perminder,  , Shahani, D. R., and Antia, F. E.
J Indian Dent Assoc 57: 453, November, 1985
A double-blind clinical study comparing the desensitizing effects
ofdentifrices containing 0.76% sodium monofluorophosphate (MFP)
and 1.3% formalin was conducted on three groups of 30 patients
each. One group served as a control and used a placebo. Each group
was instructed to use the assigned dentifrice with a toothbrush twice
daily for 5 minutes for a 6-week period. Using a Telethertnometer,
sensitivity to hot and cold was tested by increasing or decreasing the
temperature to the point where pain was felt. These values were
compared to baseline measurements. Results concluded that no dif-
ferences were found between the dentifrices for hot stimuli; however,
the MFP dentifrice was more effective than the formalin dentifrice as
far as cold response was concerned. College ofDental Surgery, Man-
ipal 576 119, Karnalaka, India. Dr. Craig Goodman
Association of Leukoplakia with ABO Blood Groups in
Southern Orissa
Vaish, R. P., Jena, D. C, Panigrahi, R. K., and Panda, R. P.
J Indian Dent Assoc 57: 459, November, 1985
Leukoplakia was diagnosed in 383 patients out of 10,000 people,
screened above the age of 14, who were examined irrespective of
complaints. ABO blood grouping was performed using high titre anti-
A and anti-B group sera by the slide method in the 383 cases
diagnosed. The normal control for blood group distribution was
recorded from the records of healthy volunteers to the blood bank.
Findings included a male predilection over females by a ratio of 3.4:1.
The maximum number of cases (32.7%) of leukoplakia were detected
among males between the ages of 40 to 49 years and among females
between 50 to 59 years. The number of people belonging to blood
group A with leukoplakia was significantly greater than that in the
control group. In all other blood groups, no significant correlations
to controls were reported. MKCG Medical College, Berhampur (Gm.),
Orissa, India. Dr. Craig S. Goodman
